KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in AZN — Astrazeneca PLC
CIK 1021223
LOS ANGELES, CA
Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,131,630
+$1,288,507 QoQ
Shares Held
21,789
+51.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#416
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. AZN ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,338 | $78,368,363 | |
| 2 | ABBV |
AbbVie Inc.
|
113,217 | $28,489,925 | |
| 3 | JNJ |
Johnson & Johnson
|
57,018 | $14,480,861 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,634 | $8,305,469 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
50,176 | $6,339,235 | |
| 6 | AMGN |
Amgen Inc
|
11,431 | $4,139,392 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
21,789 | $4,131,630 | |
| 8 | NVO |
Novo Nordisk A S
|
28,829 | $1,382,062 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,131,630 | 21,789 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,843,123 | 14,416 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||